{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:01:45Z","timestamp":1780470105397,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010751","name":"Indian Rheumatology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00296-021-04897-1","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T05:04:27Z","timestamp":1622264667000},"page":"1155-1165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-6227","authenticated-orcid":false,"given":"Sai Kumar","family":"Dunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-3989","authenticated-orcid":false,"given":"Chengappa","family":"Kavadichanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3925","authenticated-orcid":false,"given":"R.","family":"Naveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-6031","authenticated-orcid":false,"given":"Vir Singh","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"issue":"4","key":"4897_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","volume":"91","author":"NF Chaisson","year":"2012","unstructured":"Chaisson NF, Paik J, Orbai A-M, Casciola-Rosen L, Fiorentino D, Danoff S et al (2012) A novel dermato-pulmonary syndrome associated with MDA-5 antibodies. Medicine 91(4):220\u2013228","journal-title":"Medicine"},{"issue":"4","key":"4897_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jaad.2017.12.010","volume":"78","author":"DJB Kurtzman","year":"2018","unstructured":"Kurtzman DJB, Vleugels RA (2018) Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol 78(4):776\u2013785","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"4897_CR3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/acr.21992","volume":"65","author":"JC Hall","year":"2013","unstructured":"Hall JC, Casciola-Rosen L, Samedy L-A, Werner J, Owoyemi K, Danoff SK et al (2013) Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res 65(8):1307\u20131315","journal-title":"Arthritis Care Res"},{"issue":"4","key":"4897_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T et al (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147(4):391\u2013398","journal-title":"Arch Dermatol"},{"issue":"9","key":"4897_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10067-015-2935-9","volume":"34","author":"Z Chen","year":"2015","unstructured":"Chen Z, Hu W, Wang Y, Guo Z, Sun L, Kuwana M (2015) Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis\/dermatomyositis. Clin Rheumatol 34(9):1627\u20131631","journal-title":"Clin Rheumatol"},{"key":"4897_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48\u201355","journal-title":"J Autoimmun"},{"issue":"7","key":"4897_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","volume":"57","author":"S Sato","year":"2018","unstructured":"Sato S, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Tamura M et al (2018) Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology 57(7):1212\u20131221","journal-title":"Rheumatology"},{"issue":"11","key":"4897_CR8","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/gb-2010-11-11-r113","volume":"11","author":"J Xing","year":"2010","unstructured":"Xing J, Watkins WS, Hu Y, Huff CD, Sabo A, Muzny DM et al (2010) Genetic diversity in India and the inference of Eurasian population expansion. Genome Biol 11(11):R113","journal-title":"Genome Biol"},{"issue":"5","key":"4897_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/tan.12910","volume":"88","author":"CM Mariaselvam","year":"2016","unstructured":"Mariaselvam CM, Fortier C, Charron D, Krishnamoorthy R, Tamouza R, Negi VS (2016) HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population. HLA 88(5):253\u2013258","journal-title":"HLA"},{"issue":"10","key":"4897_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00296-016-3529-9","volume":"36","author":"R Srivastava","year":"2016","unstructured":"Srivastava R, Phatak S, Yadav A, Bajpai P, Aggarwal A (2016) HLA B27 typing in 511 children with juvenile idiopathic arthritis from India. Rheumatol Int 36(10):1407\u20131411","journal-title":"Rheumatol Int"},{"issue":"7","key":"4897_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/1756-185X.13551","volume":"22","author":"CG Kavadichanda","year":"2019","unstructured":"Kavadichanda CG, Seth G, Kumar G, Gulati R, Negi VS (2019) Clinical correlates of HLA-B*27 and its subtypes in enthesitis-related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients. Int J Rheum Dis 22(7):1289\u20131296","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"4897_CR12","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar3547","volume":"13","author":"Y Muro","year":"2011","unstructured":"Muro Y, Sugiura K, Hoshino K, Akiyama M, Tamakoshi K (2011) Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res Ther 13(6):R214","journal-title":"Arthritis Res Ther"},{"key":"4897_CR13","unstructured":"Census of India: Reference Material (2020) https:\/\/censusindia.gov.in\/Ad_Campaign\/Referance_material.html. Accessed 7 Dec 2020"},{"issue":"12","key":"4897_CR14","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964","journal-title":"Ann Rheum Dis"},{"issue":"Suppl S2","key":"4897_CR15","first-page":"99","volume":"14","author":"KG Chengappa","year":"2019","unstructured":"Chengappa KG, Adarsh MB, Negi VS, Saikumar D (2019) PC0098: clinical and immunological profile of patients with idiopathic inflammatory myopathies in a tertiary care hospital. Indian J Rheumatol 14(Suppl S2):99\u2013249","journal-title":"Indian J Rheumatol"},{"key":"4897_CR16","doi-asserted-by":"publisher","DOI":"10.4103\/injr.injr_56_20","author":"P Mehta","year":"2020","unstructured":"Mehta P, Gupta L (2020) Combined case record forms for collaborative datasets of patients and controls of idiopathic inflammatory myopathies. Indian J Rheumatol. https:\/\/doi.org\/10.4103\/injr.injr_56_20","journal-title":"Indian J Rheumatol"},{"issue":"2","key":"4897_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/injr.injr_40_19","volume":"14","author":"L Gupta","year":"2019","unstructured":"Gupta L, Appani SK, Janardana R, Muhammed H, Lawrence A, Amin S et al (2019) Meeting report: MyoIN\u2014Pan-India collaborative network for myositis research. Indian J Rheumatol 14(2):136","journal-title":"Indian J Rheumatol"},{"issue":"6","key":"4897_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/injr.injr_95_20","volume":"15","author":"R Naveen","year":"2020","unstructured":"Naveen R, Anuja A, Rai M, Agarwal V, Gupta L (2020) Development of the myocite biobank: cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis. Indian J Rheumatol 15(6):194","journal-title":"Indian J Rheumatol"},{"issue":"1","key":"4897_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.semarthrit.2020.10.014","volume":"51","author":"L Gupta","year":"2021","unstructured":"Gupta L, Naveen R, Gaur P, Agarwal V, Aggarwal R (2021) Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis. Semin Arthritis Rheum 51(1):113\u2013120","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4897_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","volume":"14","author":"LG Rider","year":"2018","unstructured":"Rider LG, Aggarwal R, Machado PM, Hogrel J-Y, Reed AM, Christopher-Stine L et al (2018) Update on outcome assessment in myositis. Nat Rev Rheumatol 14(5):303\u2013318","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4897_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chest.2020.01.033","volume":"158","author":"R Jablonski","year":"2020","unstructured":"Jablonski R, Bhorade S, Strek ME, Dematte J (2020) Recognition and management of myositis-associated rapidly progressive interstitial lung disease. Chest 158(1):252\u2013263","journal-title":"Chest"},{"issue":"2","key":"4897_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized placebo-phase. Trial Arthritis Rheum 65(2):314\u2013324","journal-title":"Trial Arthritis Rheum"},{"issue":"9631","key":"4897_CR23","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman BM, Rider LG, Reed AM, Pachman LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371(9631):2201\u20132212","journal-title":"Lancet"},{"key":"4897_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04819-1","author":"PM Machado","year":"2021","unstructured":"Machado PM, Mehta P, Gupta L (2021) Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-04819-1","journal-title":"Rheumatol Int"},{"key":"4897_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa821\/6025468","author":"U Rathore","year":"2020","unstructured":"Rathore U, Haldule S, Gupta L (2020) Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keaa821\/6025468","journal-title":"Rheumatology"},{"issue":"7","key":"4897_CR26","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T et al (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 60(7):2193\u20132200","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4897_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/acr.22728","volume":"68","author":"S Moghadam-Kia","year":"2016","unstructured":"Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R (2016) Anti-melanoma differentiation-associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with amyopathic and myopathic dermatomyositis. Arthritis Care Res 68(5):689\u2013694","journal-title":"Arthritis Care Res"},{"issue":"8","key":"4897_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/0961203316651748","volume":"25","author":"R Nakashima","year":"2016","unstructured":"Nakashima R, Hosono Y, Mimori T (2016) Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25(8):925\u2013933","journal-title":"Lupus"},{"issue":"1","key":"4897_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. J Am Acad Dermatol 65(1):25\u201334","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4897_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/acr.22498","volume":"67","author":"NS Narang","year":"2015","unstructured":"Narang NS, Casciola-Rosen L, Li S, Chung L, Fiorentino DF (2015) Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease: analysis of skin ulcers in dermatomyositis. Arthritis Care Res 67(5):667\u2013672","journal-title":"Arthritis Care Res"},{"issue":"12","key":"4897_CR31","first-page":"1383","volume":"129","author":"R Tomb","year":"2002","unstructured":"Tomb R, Stephan F (2002) Perforating skin ulcers occurring in an adult with dermatomyositis. Ann Dermatol Venereol 129(12):1383\u20131385","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"4897_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10067-004-1050-0","volume":"24","author":"S Nakamura","year":"2004","unstructured":"Nakamura S, Nakagawa J (2004) Recurrent extensor tendon rupture in adult-onset dermatomyositis: a case report. Clin Rheumatol 24(4):409\u2013410","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4897_CR33","first-page":"21244","volume":"20","author":"J Tu","year":"2014","unstructured":"Tu J, McLean-Tooke A, Junckerstorff R (2014) Increasing recognition of dermatomyositis with subcutaneous edema\u2014is this a poorer prognostic marker? Dermatol Online J 20(1):21244","journal-title":"Dermatol Online J"},{"key":"4897_CR34","first-page":"60","volume":"7","author":"E Pappa","year":"2018","unstructured":"Pappa E, Gkeka M, Protogerou A, Marinos L, Loupa C, Christopoulos C (2018) Case report: clinically amyopathic dermatomyositis presenting acutely with isolated facial edema. F1000Research 7:60","journal-title":"F1000Research"},{"issue":"2","key":"4897_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semarthrit.2014.04.004","volume":"44","author":"JC Milisenda","year":"2014","unstructured":"Milisenda JC, Doti PI, Prieto-Gonz\u00e1lez S, Grau JM (2014) Dermatomyositis presenting with severe subcutaneous edema: five additional cases and review of the literature. Semin Arthritis Rheum 44(2):228\u2013233","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"4897_CR36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/acr.21992","volume":"65","author":"JC Hall","year":"2013","unstructured":"Hall JC, Casciola-Rosen L, Samedy L-A, Werner J, Owoyemi K, Danoff SK et al (2013) Anti-MDA5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res 65(8):1307\u20131315","journal-title":"Arthritis Care Res"},{"key":"4897_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.rmed.2019.07.020","volume":"155","author":"F Chen","year":"2019","unstructured":"Chen F, Zuo Y, Li S, Shi J, Wang G, Shu X (2019) Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: data from the largest single Chinese center. Respir Med 155:127\u2013132","journal-title":"Respir Med"},{"issue":"9","key":"4897_CR38","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","volume":"49","author":"K Hoshino","year":"2010","unstructured":"Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T (2010) Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology 49(9):1726\u20131733","journal-title":"Rheumatology"},{"issue":"9","key":"4897_CR39","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y et al (2012) Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology 51(9):1563\u20131570","journal-title":"Rheumatology"},{"issue":"4","key":"4897_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","volume":"157","author":"P Gerami","year":"2007","unstructured":"Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD (2007) A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol 157(4):637\u2013644","journal-title":"Br J Dermatol"},{"issue":"4","key":"4897_CR41","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C et al (2014) Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 16(4):R138","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"4897_CR42","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3899\/jrheum.170165","volume":"44","author":"Z Chen","year":"2017","unstructured":"Chen Z, Wang Y, Kuwana M, Xu X, Hu W, Feng X et al (2017) HLA-DRB1 alleles as genetic risk factors for the development of anti-MDA5 antibodies in patients with dermatomyositis. J Rheumatol 44(9):1389\u20131393","journal-title":"J Rheumatol"},{"issue":"11","key":"4897_CR43","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1002\/art.34657","volume":"64","author":"T Gono","year":"2012","unstructured":"Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K et al (2012) Brief Report: Association of HLA\u2013DRB1*0101\/*0405 with susceptibility to anti\u2013melanoma differentiation\u2013associated gene 5 antibody\u2013positive dermatomyositis in the Japanese population. Arthritis Rheum 64(11):3736\u20133740","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4897_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/tan.13171","volume":"90","author":"JM Lin","year":"2017","unstructured":"Lin JM, Zhang YB, Peng QL, Yang HB, Shi JL, Gu ML et al (2017) Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population. HLA 90(6):354\u2013359","journal-title":"HLA"},{"issue":"1","key":"4897_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","volume":"8","author":"C Vuillard","year":"2018","unstructured":"Vuillard C, de Pineton Chambrun M, de Prost N, Gu\u00e9rin C, Schmidt M, Dargent A et al (2018) Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study. Ann Intensive Care 8(1):87","journal-title":"Ann Intensive Care"},{"issue":"4","key":"4897_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","volume":"50","author":"F Romero-Bueno","year":"2020","unstructured":"Romero-Bueno F, Diaz Del Campo P, Trallero-Aragu\u00e1s E, Ruiz-Rodr\u00edguez JC, Castellvi I, Rodriguez-Nieto MJ et al (2020) Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Semin Arthritis Rheum 50(4):776\u2013790","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"4897_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","volume":"6","author":"JC Hall","year":"2010","unstructured":"Hall JC, Rosen A (2010) Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 6(1):40\u201349","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"4897_CR48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/rheumatology\/keaa033","volume":"59","author":"N Ono","year":"2020","unstructured":"Ono N, Kai K, Maruyama A, Sakai M, Sadanaga Y, Koarada S et al (2020) The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients. Rheumatology 59(4):918","journal-title":"Rheumatology"},{"issue":"4","key":"4897_CR49","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1084\/jem.181.4.1557","volume":"181","author":"A Rosen","year":"1995","unstructured":"Rosen A, Casciola-Rosen L, Ahearn J (1995) Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 181(4):1557\u20131561","journal-title":"J Exp Med"},{"issue":"3","key":"4897_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/03009742.2017.1334814","volume":"47","author":"S Hoa","year":"2018","unstructured":"Hoa S, Troyanov Y, Fritzler MJ, Targoff IN, Chartrand S, Mansour AM et al (2018) Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review. Scand J Rheumatol 47(3):210\u2013224","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"4897_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","volume":"56","author":"S Sakamoto","year":"2018","unstructured":"Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M et al (2018) Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Respir Investig 56(6):464\u2013472","journal-title":"Respir Investig"},{"issue":"2","key":"4897_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A et al (2017) Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol 176(2):395\u2013402","journal-title":"Br J Dermatol"},{"issue":"5","key":"4897_CR53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1684\/ejd.2019.3634","volume":"29","author":"S-I Motegi","year":"2019","unstructured":"Motegi S-I, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M et al (2019) Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease. Eur J Dermatol EJD 29(5):511\u2013517","journal-title":"Eur J Dermatol EJD"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04897-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04897-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04897-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T10:25:01Z","timestamp":1655375101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04897-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4897"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04897-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"3 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments after obtaining clearance independently from Jawaharlal institute of postgraduate medical education and research institute ethics committee(JIP\/IEC\/2019\/250) and Sanjay Gandhi postgraduate Institute\u2019s institute ethics committee (2017-41-IP-76).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A written informed consent was obtained from the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}